LIV DIAGNOSTICS

Liv Diagnostics develops a unique product for measuring the migration capacity of tumor cells. It provides predictive information about the risk of metastasis. Liv Diagnostics' technology is based on direct analysis of cancer cell behavior, which is a new approach in comparison with indirect diagnostic methods, allowing physicians to mimic the cells' natural environment in the human body to directly observe how the cells behave and treat efficiently. Liv Diagnostics' product, CellRACE, provides quantified information on the risk of metastasis by analyzing the migration behavior of living cells. Liv Diagnostics was founded in 2016 and is headquartered in Mölndal, Sweden.